Bipartisan bill strengthens counterfeiting penalties
The Counterfeit Drug Prevention Act of 2007 amends the Federal Food, Drug, and Cosmetic Act.
A new bill has been introduced in the House of Representatives that would increase penalties for knowingly creating, distributing, or dispensing counterfeit medications. The Counterfeit Drug Prevention Act of 2007 amends the Federal Food, Drug, and Cosmetic Act, raising the maximum imprisonment to up to 20 years in jail. The bill is sponsored by Mike Rogers (R, Mich.) and Gene Green (D, Texas). At a briefing about the bill, Carmen Catizone, executive director of NABP, voiced his support for the bill. "NABP believes it is essential that the problem of counterfeiting be recognized at both the national and local level," he said.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
